Stelazine

Stelazine is a psychotropic drug prescribed to Billy Milligan during his hospitalization at Lima State Hospital. Its place in the account is defined by two different perspectives: a physician described the medication as having no observed beneficial effect, while Billy later said it had affected him badly.

Prescription and Clinical Assessment

In discussing treatment at Lima, the book reports that clinical director Lewis Lindner diagnosed Billy as a pseudo-psychopathic schizophrenic and prescribed Stelazine. The drug is described as belonging to the same family as Thorazine, which the account associates with worsening the splitting.

A separate account of the hospital treatment comes from Frederick Milkie’s testimony. He said he had prescribed five milligrams of Stelazine, observed no ill effects, and discontinued it because he saw no benefit. The available account does not resolve how this prescription relates to Lindner’s: it presents both the initial prescription attributed to Lindner and Milkie’s later testimony about prescribing and stopping the medication.

Billy’s Account and Its Significance

At a hearing concerning his treatment, Billy said that Stelazine had adversely affected him. His statement differs in emphasis from Milkie’s clinical account: Milkie reported neither harmful effects nor improvement, whereas Billy identified the drug as a negative part of his experience at Lima.

Stelazine therefore appears not as a treatment shown to have helped Billy, but as a contested element of his care. The contrast between the physician’s report and Billy’s testimony preserves the difference between an observed clinical outcome and the patient’s own account of treatment.